NCT03500068View on ClinicalTrials.gov

Establishing Organoids From Metastatic Pancreatic Cancer Patients, the OPT-I Study.

NAUnknownINTERVENTIONAL

Enrollment

30

Participants

Timeline

Start Date

September 4, 2017

Primary Completion Date

September 1, 2022

Study Completion Date

September 1, 2022

Conditions

Carcinoma, Pancreatic Ductal

Interventions

DIAGNOSTIC_TEST

biopsies & blood analyses

They will take blood and a biopsy from the metastase in the patient

Trial Locations (1)

1100 DD

RECRUITING

Academic Medical Center, Medical Oncology, Amsterdam

Sponsors

Collaborators (1)

Erasmus Medical Center

All Listed Sponsors

collaborator

Erasmus Medical Center

OTHER

lead

Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

OTHER